Table 1 Clinical and biochemical characteristics of study participants in mean (SD) or n (%)
Characteristic | Female (n = 83) | Male (n = 117) | p value | All participants(n = 200) |
|---|---|---|---|---|
Age (years) | 56.5 (12.5) | 57.4 (11.3) | 0.65 | 56.9 (11.8) |
Duration of DM (years) | 9.2 (6.9) | 8.3 (6.8) | 0.39 | 8.7 (6.8) |
Presence of Hypertension | 61 (73.5) | 79 (67.5) | 0.36 | 140 (70.0) |
Previous Tobacco Smoking* | 0 (0.0) | 9 (7.7) | 0.01 | 9 (4.5) |
Previous MI or stroke | 4 (4.8) | 8 (6.8) | 0.55 | 12 (6.0) |
Medications | ||||
Antihypertensives | 60 (72.3) | 74 (63.2) | 0.18 | 134 (67.0) |
Lipid lowering drugs | 11 (13.3) | 14 (12.0) | 0.79 | 21 (12.5) |
Antiplatelets | 15 (18.1) | 22 (18.8) | 0.90 | 37 (18.5) |
BMI (Kg/m2)* | 29.3 (5.4) | 27.0 (5.1) | < 0.01 | 27.9 (5.4) |
Waist circumference (cm) | 97.6 (9.9) | 94.6 (12.2) | 0.05 | 95.8 (11.4) |
HbA1c (%) | 10.3 (3.1) | 9.9 (3.1) | 0.32 | 10.1 (3.1) |
Total cholesterol (mmol/L)* | 4.5 (0.9) | 4.1 (1.0) | 0.01 | 4.20 (1.0) |
LDL cholesterol (mmol/L) | 2.7 (0.9) | 2.5 (0.9) | 0.14 | 2.6 (0.5) |
HDLcholesterol (mmol/L)* | 1.0 (0.4) | 0.9 (0.4) | < 0.01 | 0.95 (0.4) |
Triglycerides (mmol/L) | 1.5 (0.7) | 1.6 (1.1) | 0.65 | 1.5 (0.9) |
PAD* | 39 (47.0) | 38 (32.5) | 0.04 | 77 (38.5) |